Scientific Advisory Board
We are pleased to announce the constitution of our Scientific Advisory Board composed of world-class academic experts and key opinion leaders in the field of theranostics applied to precision oncology.
Prof. Dr. med. Richard P. Baum
DKD Helios Klinik, Wiesbaden, Germany
Prof. Dr. Hans-Jürgen Biersack
Clinic and Polyclinic of the University of Bonn, Germany
PD Dr. Med Patricia Grabowski
Charité Berlin, Germany
Prof. Dr. Michael Hofman
Peter MacCallum Cancer Centre, Melbourne, Australia
Dr. Sze Ting Lee
Olivia Newton-John Cancer Research Institute, Melbourne, Australia
Professor Dr. Chen Liu
Peking University Cancer Hospital, Peking, China
PD Dr. Cristina Müller
ETH Zurich, Switzerland
Prof. Dr. Marianne Pavel
University of Erlangen, Germany
Prof. Dr. Martin Pomper
Johns Hopkins University School of Medicine, Baltimore, USA
Prof. Dr. Vikas Prasad
University of Ulm, Germany
Prof. Dr. Frank Rösch
Johannes Gutenberg-University Mainz, Germany
Prof. Dr. A. Oliver Sartor
Medical Director, Tulane Cancer Center; C. E. and Bernadine Laborde Professor of Cancer Research, USA
Prof. Dr. Mike Sathekge
University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa
Prof. Dr. Wolff H. Schmiegel
Bergmannsheil University Hospital at the Ruhr University, Bochum, Germany
Prof. Dr. Andrew Scott
Olivia Newton-John Cancer Research Institute, Melbourne, Australia
Dr. Ralph Wirtz
Stratifyer Molecular Pathology GmbH, Cologne, Germany